Cysteine dioxygenase
Cysteine dioxygenase (CDO) is an enzyme that in humans is encoded by the CDO1 gene. This enzyme is of significant interest in the fields of medicine and biochemistry due to its role in metabolism of the amino acid cysteine. Cysteine dioxygenase plays a critical role in the catabolism of cysteine, converting it into cysteine sulfinic acid, a precursor for taurine, pyruvate, and sulfate production.
Function[edit | edit source]
Cysteine dioxygenase is a metalloprotein, requiring iron as a cofactor to catalyze the incorporation of oxygen into cysteine to form cysteine sulfinic acid. This reaction is crucial for the regulation of cysteine levels within the body and for the prevention of toxicity related to excess cysteine. The activity of CDO is tightly regulated by the levels of cysteine in the body, ensuring that cysteine homeostasis is maintained.
Clinical Significance[edit | edit source]
Alterations in the activity or expression of cysteine dioxygenase can lead to disturbances in cysteine and sulfur metabolism, contributing to various diseases and disorders. Abnormal CDO activity has been linked to neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, where dysregulation of sulfur amino acid metabolism is observed. Additionally, mutations in the CDO1 gene have been associated with certain types of cancer, suggesting a role for cysteine metabolism in tumorigenesis.
Structure[edit | edit source]
The structure of cysteine dioxygenase is characterized by a unique iron-binding site that is essential for its enzymatic activity. The coordination of iron within the enzyme allows for the efficient transfer of oxygen to cysteine, facilitating the conversion to cysteine sulfinic acid. The three-dimensional structure of CDO has been elucidated through X-ray crystallography, providing insights into its mechanism of action and the basis for its specificity towards cysteine.
Genetic Regulation[edit | edit source]
The expression of the CDO1 gene is regulated by dietary and cellular levels of cysteine. High levels of cysteine induce the expression of CDO, leading to increased enzyme activity and enhanced metabolism of cysteine. This regulatory mechanism ensures that excess cysteine is promptly degraded, preventing its accumulation and potential toxicity.
Therapeutic Potential[edit | edit source]
Given its central role in cysteine metabolism, cysteine dioxygenase is considered a potential therapeutic target for diseases associated with dysregulation of sulfur amino acid metabolism. Modulating CDO activity could offer a novel approach for the treatment of neurodegenerative diseases, cancer, and other conditions linked to altered cysteine and sulfur metabolism.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD